Meanwhile, the viability of Hep G2 cells only decreased to approximately 85% in chitosan-silica
nanoparticle (CSNP) or silica nanoparticle (SNP) treatments, which without ACE polysaccharides
were loaded even at the highest concentration of 667 μg/mL for 48 h incubation (Fig 1c).